Boston Scientific Corp
XMUN:BSX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Economic Moat
Boston Scientific has a narrow economic moat
Protected device designs and the time needed to win medical approvals make Boston Scientific’s products difficult to copy. Hospitals also invest in compatible equipment and staff training, making a move to another supplier more work than simply choosing a cheaper device. These barriers protect parts of its business rather than keeping competitors out altogether.
What protects Boston Scientific from competitors
Intangible Assets
Boston Scientific’s patents protect device designs, while approvals for products such as WATCHMAN and FARAPULSE require clinical evidence that competitors must build for their own devices. Rivals cannot simply copy these products and immediately sell them, which helps protect the company’s profits.
High Switching Costs
FARAPULSE uses compatible generators and catheters and requires device-specific staff training, while LATITUDE programming equipment works with Boston Scientific implants. These connections make switching more costly because hospitals may need different equipment, additional training and changes to patient-care routines.
What could weaken Boston Scientific's moat
2 risks to watch
One for each source of the moat: what could happen and how it would weaken it
Peer Comparison
2 of 6 peers have a wide moat.
Stryker SYK
Wide
High Switching Costs, Intangible Assets
Intuitive Surgical ISRG
Wide
High Switching Costs, Intangible Assets
Abbott Laboratories ABT
Narrow
High Switching Costs, Intangible Assets
Medtronic MDT
Narrow
High Switching Costs, Intangible Assets
Becton Dickinson and BDX
Narrow
High Switching Costs, Intangible Assets
Edwards Lifesciences EW
Narrow
High Switching Costs, Intangible Assets